Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM, Tsuji M, Wise MG, Hackel M, Yamano Y, Echols R, Sahm DF. Kazmierczak KM, et al. Among authors: sahm df. Int J Antimicrob Agents. 2019 Feb;53(2):177-184. doi: 10.1016/j.ijantimicag.2018.10.007. Epub 2018 Oct 26. Int J Antimicrob Agents. 2019. PMID: 30395986 Free article.
Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network.
Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF. Karlowsky JA, et al. Among authors: sahm df. Int J Antimicrob Agents. 2002 Jan;19(1):21-31. doi: 10.1016/s0924-8579(01)00466-6. Int J Antimicrob Agents. 2002. PMID: 11814764
In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapy.
Wenzel RP, Sahm DF, Thornsberry C, Draghi DC, Jones ME, Karlowsky JA. Wenzel RP, et al. Among authors: sahm df. Antimicrob Agents Chemother. 2003 Oct;47(10):3089-98. doi: 10.1128/AAC.47.10.3089-3098.2003. Antimicrob Agents Chemother. 2003. PMID: 14506014 Free PMC article.
In vitro antimicrobial activity of doripenem, a new carbapenem.
Ge Y, Wikler MA, Sahm DF, Blosser-Middleton RS, Karlowsky JA. Ge Y, et al. Among authors: sahm df. Antimicrob Agents Chemother. 2004 Apr;48(4):1384-96. doi: 10.1128/AAC.48.4.1384-1396.2004. Antimicrob Agents Chemother. 2004. PMID: 15047550 Free PMC article.
319 results